(Uses of iridium 191 from the osmium 191/iridium 191 generator system)
The traveler was an invited speaker at the 30th Commemorative Meeting of the Finnish Society of Nuclear Medicine on March 2--3 in Helsinki, Finland. He described the development, initial clinical applications, and future use of iridium-191m from the osmium-191/-iridium-191m generator system developed at the Oak Ridge National Laboratory (ORNL). He also visited the university hospitals in Kupio and Turku, Finland, and presented seminars on the use of iridium-191m and iodine-123-labeled fatty acids for cardiac studies. He visited the Clinic for Nuclear Medicine in Bonn, West Germany, and the Cyclotron Research Center (CRC) in Liege, Belgium, to coordinate collaborative projects on research and clinical applications of various radiopharmaceuticals.
- Research Organization:
- Oak Ridge National Lab., TN (USA)
- Sponsoring Organization:
- DOE/ER
- DOE Contract Number:
- AC05-84OR21400
- OSTI ID:
- 6983747
- Report Number(s):
- ORNL/FTR-3548; ON: DE90008550
- Country of Publication:
- United States
- Language:
- English
Similar Records
(Radioiodinated free fatty acids)
New osmium-191. -->. iridium-191m generator
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
BELGIUM
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARDIOVASCULAR SYSTEM
DAYS LIVING RADIOISOTOPES
DRUGS
EUROPE
EVEN-ODD NUCLEI
FEDERAL REPUBLIC OF GERMANY
FINLAND
HEART
HEAVY NUCLEI
HOURS LIVING RADIOISOTOPES
IRIDIUM 191
IRIDIUM ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MEDICINE
MEETINGS
MINUTES LIVING RADIOISOTOPES
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
OPTIMIZATION
ORGANS
OSMIUM 191
OSMIUM ISOTOPES
RADIOISOTOPES
RADIOPHARMACEUTICALS
SCANDINAVIA
SECONDS LIVING RADIOISOTOPES
STABLE ISOTOPES
TRAVEL
WESTERN EUROPE